Table of Content

1. Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders

2. Research Methodology
2.1. Research Process
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.1.1. Bottom-up Approach
2.3.1.2. Top-down Approach
2.3.1.3. Growth Forecast
2.3.2. Market Share Analysis
2.4. Assumptions for the Study
2.5. Limitations for the Study

3. Executive Summary

4. Market Insights
4.1. Introduction
4.2. Drivers
4.2.1. Rising Focus on Reducing Turnaround Time in Drug Discovery
4.2.2. Increasing Investment in Genomics
4.2.3. Growing Need for and Application of AI in Genomics
4.3. Restraints
4.3.1. Limited Availability of Resources for Integration of Artificial Intelligence in Genomics
4.4. Opportunity
4.4.1. Emerging Economies
4.4.2. Rising Focus on the Development of Personalized Medicines
4.5. Challenges
4.5.1. Ambiguous Regulatory Guidelines for Genomics Software
4.5.2. Poor Security & Storage of Large Volumes of Genome Sequencing Data
4.6. Impact of COVID-19

5. Global Artificial Intelligence in Genomics Market, by Offering
5.1. Introduction
5.2. Software
5.3. Services

6. Global Artificial Intelligence in Genomics, by Delivery Mode
6.1. Introduction
6.2. Cloud & Web-based Mode
6.3. On-premise Mode

7. Global Artificial Intelligence in Genomics, by Functionality
7.1. Introduction
7.2. Genome Sequencing
7.3. Gene Editing
7.4. Other Functionalities

8. Global Artificial Intelligence in Genomics Market, by Application
8.1. Introduction
8.2. Drug Discovery & Development
8.3. Precision Medicine
8.4. Diagnostics
8.5. Other Applications

9. Global Artificial Intelligence in Genomics Market, by End User
9.1. Introduction
9.2. Pharmaceutical & Biotechnology Companies
9.3. Academic & Research Institutes
9.4. Other End Users

10. Artificial Intelligence in Genomics Market, by Geography
10.1. Introduction
10.2. North America
10.2.1. U. S.
10.2.2. Canada
10.3. Europe
10.3.1. Germany
10.3.2. France
10.3.3. U.K.
10.3.4. Italy
10.3.5. Spain
10.3.6. Rest of Europe
10.4. Asia-Pacific
10.4.1. China
10.4.2. Japan
10.4.3. India
10.4.4. Rest of Asia-Pacific
10.5. Latin America
10.5.1. Brazil
10.5.2. Mexico
10.5.3. Rest of Latin America
10.6. Middle East & Africa

11. Competitive Landscape
11.1. Introduction
11.2. Key Growth Strategies
11.3. Competitive Benchmarking
11.4. Market Share Analysis (2021)
11.4.1. NVIDIA Corporation (U.S.)
11.4.2. Microsoft Corporation (U.S.)
11.4.3. Illumina, Inc. (U.S.)

12. Company Profiles (Business Overview, Financial Overview, Solutions Portfolio, Strategic Developments)
12.1. Microsoft Corporation
12.2. NVIDIA Corporation
12.3. Deep Genomics Incorporated
12.4. Fabric Genomics, Inc.
12.5. Data4cure, Inc.
12.6. Predictive Oncology Inc.
12.7. Emedgene Technologies Ltd
12.8. Congenica Ltd.
12.9. Tempus Labs, Inc.
12.10. SOPHiA GENETICS SA
12.11. Illumina, Inc.
12.12. BenevolentAI Limited

13. Appendix
13.1. Questionnaire
13.2. Available Customization



List of Figures

List of Figures

Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Size Estimation
Figure 7 Global AI in Genomics Market Size, by Offering, 2022–2029 (USD Million)
Figure 8 Global Artificial Intelligence in Genomics Market Size, by Delivery Mode, 2022–2029 (USD Million)
Figure 9 Global AI in Genomics Market Size, by Functionality, 2022–2029 (USD Million)
Figure 10 Global AI in Genomics Market Size, by Application, 2022–2029 (USD Million)
Figure 11 Global AI in Genomics Market Size, by End User, 2022–2029 (USD Million)
Figure 12 Global AI in Genomics Market, by Geography
Figure 13 Market Dynamics: AI in Genomics Market
Figure 14 Global Rise in the Number of Personalized Medicines, 2008–2020
Figure 15 Global AI in Genomics Market Size, by Offering, 2022 Vs. 2029 (USD Million)
Figure 16 Global AI in Genomics Market Size, by Delivery Mode, 2022 Vs. 2029 (USD Million)
Figure 17 Global AI in Genomics Market Size, by Functionality, 2022 Vs. 2029 (USD Million)
Figure 18 Global AI in Genomics Market Size, by Application, 2022 Vs. 2029 (USD Million)
Figure 19 Global AI in Genomics Market Size, by End User, 2022 Vs. 2029 (USD Million)
Figure 20 Global AI in Genomics Market Size, by Geography, 2022–2029 (USD Million)
Figure 21 North America: AI in Genomics Market Snapshot
Figure 22 Europe: AI in Genomics Market Snapshot
Figure 23 Asia-Pacific: AI in Genomics Market Size Snapshot
Figure 24 Latin America: AI in Genomics Market Size Snapshot
Figure 25 Key Growth Strategies Adopted by Leading Players, 2020–2022
Figure 26 AI in Genomics Market: Competitive Benchmarking by Functionality
Figure 27 AI in Genomics Market: Competitive Benchmarking by Geography
Figure 28 Market Share Analysis: AI in Genomics Market, 2021
Figure 29 Microsoft Corporation: Financial Overview (2022)
Figure 30 NVIDIA Corporation: Financial Overview (2022)
Figure 31 Predictive Oncology Inc.: Financial Overview (2021)
Figure 32 SOPHiA GENETICS SA: Financial Overview (2021)
Figure 33 Illumina, Inc.: Financial Overview (2021)
Figure 34 BenevolentAI Limited: Financial Overview (2021)